Vivimed Labs has informed that the Board meeting for considering / approving the un-audited Financial Results of the Company for the quarter & half year ended September 30, 2015 will be held on November 10, 2015. In view of this, pursuant to SEBI (Prohibition of Insider Trading) Regulations and Company’s Internal Code for Prevention of Insider Trading, the trading window for dealing in securities of the Company shall remain closed from October 31, 2015 to November 10, 2015 and shall reopen after the expiry of 48 hours after the public announcement of un audited financial results is made.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: